Cohen Jacob D.
Known title: Chief Executive OfficerCIK: 0001432078
Cohen Jacob D.'s purchase track record
Cohen Jacob D. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/10/2023 | MGRX | $275K | +91.3% | -37.0% | +5.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| MGRX | ▼ Sell | Gift | 2,000,000 | $0 | 8/11/2026 | View on chart |
| MGRX | ▼ Sell | Gift | 2,000,000 | $0 | 8/11/2026 | View on chart |
| MGRX | ▲ Buy | Grant | 2,000,000 | $0 | 7/28/2026 | View on chart |
| MGRX | ▼ Sell | Gift | 500,000 | $0 | 9/30/2025 | View on chart |
| MGRX | ▼ Sell | Gift | 500,000 | $0 | 9/30/2025 | View on chart |
| MGRX | ▲ Buy | Grant | 500,000 | $0 | 9/9/2025 | View on chart |
| MGRX | ▼ Sell | Gift | 200,000 | $0 | 6/5/2025 | View on chart |
| MGRX | ▼ Sell | Gift | 200,000 | $0 | 6/5/2025 | View on chart |
| MGRX | ▲ Buy | Grant | 200,000 | $0 | 4/10/2025 | View on chart |
| MGRX | ▲ Buy | Grant | 200,000 | $0 | 4/10/2025 | View on chart |
| MGRX | ▼ Sell | Gift | 800,000 | $0 | 8/26/2024 | View on chart |
| MGRX | ▼ Sell | Gift | 800,000 | $0 | 8/26/2024 | View on chart |
| MGRX | ▲ Buy | Grant | 800,000 | $0 | 6/3/2024 | View on chart |
| MGRX | ▲ Buy | Open Market | 275,000 | $275K | 4/10/2023 | View on chart |
| MGRX | ▼ Sell | Gift | 8,000,000 | $0 | 4/4/2023 | View on chart |
| MGRX | ▼ Sell | Gift | 8,000,000 | $0 | 4/4/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
MGRX Shares Drop 12% After Hours Amid $2.5M Investment Announcement
Mangoceuticals shares fell 12% in after‑hours trading after the company announced a $2.5 million investment in its MangoRx IP. The deal provides an initial $1.75 million tranche and additional funding from strategic investors. Despite the funding, the market reacted negatively, pulling the stock lower. The move highlights the volatility around the company’s valuation.
MGRX Shares Drop 12% After Hours Amid $2.5M Investment Announcement. Mangoceuticals shares fell 12% in after‑hours trading after the company announced a $2.5 million investment in its MangoRx IP. The deal provides an initial $1.75 million tranche and additional funding from strategic investors. Despite the funding, the market reacted negatively, pulling the stock lower. The move highlights the volatility around the company’s valuation.